Browsing Research Articles (Medical Microbiology) by Author "Andres, Sonke"

Browsing Research Articles (Medical Microbiology) by Author "Andres, Sonke"

Sort by: Order: Results:

  • Zignol, Matteo; Cabibbe, Andrea Maurizio; Dean, Anna S.; Glaziou, Philippe; Alikhanova, Natavan; Ama, Cecilia; Andres, Sonke; Barbova, Anna; Borbe-Reyes, Angeli; Chin, Daniel P.; Cirillo, Daniela Maria; Colvin, Charlotte; Dadu, Andrei; Dreyer, Andries; Driesen, Michele; Gilpin, Christopher; Hasan, Rumina; Hasan, Zahra; Hoffner, Sven; Hussain, Alamdar; Ismail, Nazir Ahmed; Kamal, S.M. Mostofa; Khanzada, Faisal Masood; Kimerling, Michael; Kohl, Thomas Andreas; Mansjo, Mikael; Miotto, Paolo; Mukadi, Ya Diul; Mvusi, Lindiwe; Niemann, Stefan; Omar, Shaheed Vally; Rigouts, Leen; Schito, Marco; Sela, Ivita; Seyfaddinova, Mehriban; Skenders, Girts; Skrahina, Alena; Tahseen, Sabira; Wells, William A.; Zhurilo, Alexander; Weyer, Karin; Floyd, Katherine; Raviglione, Mario C. (Elsevier, 2018-06)
    BACKGROUND : In many countries, regular monitoring of the emergence of resistance to anti-tuberculosis drugs is hampered by the limitations of phenotypic testing for drug susceptibility. We therefore evaluated the use ...
  • Beckert, Patrick; Sanchez-Padilla, Elisabeth; Merker, Matthias; Dreyer, Viola; Kohl, Thomas A.; Utpatel, Christian; Köser, Claudio U.; Barilar, Ivan; Ismail, Nazir Ahmed; Omar, Shaheed Vally; Klopper, Marisa; Warren, Robin M.; Hoffmann, Harald; Maphalala, Gugu; Ardizzoni, Elisa; De Jong, Bouke C.; Kerschberger, Bernhard; Schramm, Birgit; Andres, Sonke; Kranzer, Katharina; Maurer, Florian P.; Bonnet, Maryline; Niemann, Stefan (BioMed Central, 2020-12)
    BACKGROUND: Multidrug-resistant (MDR) Mycobacterium tuberculosis complex strains not detected by commercial molecular drug susceptibility testing (mDST) assays due to the RpoB I491F resistance mutation are threatening ...
  • Zignol, Matteo; Dean, Anna S.; Alikhanova, Natavan; Andres, Sonke; Cabibbe, Andrea Maurizio; Cirillo, Daniela Maria; Dadu, Andrei; Dreyer, Andries; Driesen, Michèle; Gilpin, Christopher; Hasan, Rumina; Hasan, Zahra; Hoffner, Sven; Husain, Ashaque; Hussain, Alamdar; Ismail, Nazir Ahmed; Kamal, Mostofa; Mansjo, Mikael; Mvusi, Lindiwe; Niemann, Stefan; Omar, Shaheed Vally; Qadeer, Ejaz; Rigouts, Leen; Ruesch-Gerdes, Sabine; Schito, Marco; Seyfaddinova, Mehriban; Skrahina, Alena; Tahseen, Sabira; Wells, William A.; Mukadi, Ya Diul; Kimerling, Michael; Floyd, Katherine; Weyer, Karin; Raviglione, Mario C. (Elsevier, 2016-10)
    BACKGROUND : Pyrazinamide and fluoroquinolones are essential antituberculosis drugs in new rifampicin-sparing regimens. However, little information about the extent of resistance to these drugs at the population level is ...